'Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase' - Bloomberg
https://www.bloomberg.com/news/articles/2026-10-16/kimberly-clark-preps-bond-sale-ahead-of-tylenol-maker-purchase?srnd=homepage-europe
Stocks · News reference
BNP Paribas Maintains Neutral on Kimberly-Clark, Raises Price Target to $110
BNP Paribas analyst Kevin Grundy maintains Kimberly-Clark (NASDAQ:KMB) with a Neutral and raises the price target from $101 to $110.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Nike, FMC Corp., Alcoa, Interactive Brokers and Kimberly-Clark: Why These 5 Stocks Are on Investors' Radars Today
NKE, FMC, AA, IBKR, KMB were among the stocks seen trending on Thursday, Oct. 15, 2026.
Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook
Kimberly-Clark stock rises on Q3 prelims: Adj. EPS from continuing ops hits $1.70 despite lower sales. Full-year 2026 outlook affirmed.